Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AD09	METASPRAY	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	349,399 L.L
R01AD09	MOMETASONE BIOGARAN	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	501,253 L.L
C01DX12	MOLSIDOMINE BIOGARAN	G	Molsidomine - 4mg	4mg	Tablet	344,024 L.L
C01DX12	MOLSIDOMINE BIOGARAN	G	Molsidomine - 2mg	2mg	Tablet, scored	256,674 L.L
C01DX12	MOLSIDOMINE BIOGARAN	G	Molsidomine - 2mg	2mg	Tablet, scored	713,580 L.L
N06BA07	MODAFINIL ARROW	G	Modafinil - 100mg	100mg	Tablet	5,361,932 L.L
L01DB07	MITOXANTRON EBEWE	G	Mitoxantrone - 20mg/10ml	20mg/10ml	Injectable concentrated solution	11,064,120 L.L
A02BB01	MISOFAR	G	Misoprostol - 25mcg	25mcg	Tablet	1,855,846 L.L
A02BB01	MISOFAR	G	Misoprostol - 200mcg	200mcg	Tablet	1,546,763 L.L
N06AX11	MIRTA TAD	G	Mirtazapine - 30mg	30mg	Tablet, film coated	1,138,235 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 5%	5%	Solution	3,675,409 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 2%	2%	Solution	2,839,539 L.L
C01CE02	MILRINONE	G	Milrinone - 1mg/ml	1mg/ml	Injectable concentrate for solution	28,486,446 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	826,463 L.L
N05CD08	MIDAZOLAM NORMON.	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	618,168 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	697,454 L.L
N05CD08	MIDAZOLAM HAMELN	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	561,726 L.L
N05CD08	MIDAZOLAM HAMELN	G	Midazolam (HCl) - 5mg/5ml	5mg/5ml	Injectable solution	529,474 L.L
A01AB09	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	229,093 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L
D01AC02	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	427,470 L.L
G01AF04	MYCODERM-V	G	Miconazole nitrate - 2%	2%	Cream	361,494 L.L
A01AB09	MICOZOLE	G	Miconazole - 20mg/g	20mg/g	Gel	104,820 L.L
J02AX05	MYCAMINE	B	Micafungin (sodium) - 50mg	50mg	Injectable lyophilised powder for solution	13,170,341 L.L
J02AX05	MEGMENTO	G	Micafungin (sodium) - 50mg	50mg	Injectable powder for solution	9,530,364 L.L
J02AX05	MEGMENTO	G	Micafungin (sodium) - 100mg	100mg	Injectable powder for solution	17,158,569 L.L
P01AB01	METROGYL	G	Metronidazole benzoate - 200mg/5ml	200mg/5ml	Powder for suspension	500,867 L.L
P01AB01	METRONIDAL	G	Metronidazole benzoate - 125mg/5ml	125mg/5ml	Syrup	391,634 L.L
P01AB01	METROLAG	G	Metronidazole benzoate - 125mg/5ml	125mg/5ml	Syrup	391,634 L.L
P01AB01	METROLE	G	Metronidazole benzoate - 125mg/5ml	125mg/5ml	Syrup	391,634 L.L

...